Literature DB >> 35495073

Expanding Access to Contraception: Identifying Accessibility Gaps Across Hawai'i Communities.

Alyssandra Baniqued1, Sarah Murayama1, Rochelle Mae Cadiente1, Bianca Calio1, Jessica Cabusog1, Kellie Goya1, Jasmine Tyson2, Teresa Schiff-Elfalan3, Komal Soin3, Bliss Kaneshiro2.   

Abstract

In 2019, Hawai'i ended its Title X program resulting in a loss of federal family planning funds. Additionally, physician shortages have decreased family planning resources available to patients. The objective of this study was to assess contraception availability by determining the number and location of healthcare providers in Hawai'i that prescribed at least one form of contraception. A list of healthcare providers was compiled using Google searches, major health insurance, and hospital provider directories. Providers were organized by physical location (ie, address). Each location was contacted to inquire about each provider's ability to prescribe different forms of contraception (eg, intrauterine device, implant, injection, pill, patch, or ring). Of the 1,020 locations contacted, 274 prescribed at least one form of contraception. Of the 1,810 providers surveyed at these locations, 744 prescribed at least one form of contraception. In regard to insurance, 201 locations and 609 providers accepted at least one form of Medicaid. Most prescribing providers were located on the island of O'ahu. The majority of providers across the state prescribed the pill, patch, or ring. There are many additional barriers that were not addressed in this study, including factors that affect physician prescribing practices. Identifying these barriers is important to further address gaps in contraceptive accessibility. Consideration of improved support for training in specialties such as Family Medicine, Internal Medicine, and Pediatrics can expand access to contraception within primary care settings. ©Copyright 2022 by University Health Partners of Hawai‘i (UHP Hawai‘i).

Entities:  

Keywords:  Contraception; Title X; family planning; intrauterine device

Mesh:

Year:  2022        PMID: 35495073      PMCID: PMC9036455     

Source DB:  PubMed          Journal:  Hawaii J Health Soc Welf        ISSN: 2641-5216


  7 in total

1.  Addressing the physician shortage in Hawai'i: recruiting medical students who meet the needs of Hawai'i's rural communities.

Authors:  Teresa Schiff; Jubilee Felsing-Watkins; Christian Small; Alexandra Takayesu; Kelley Withy
Journal:  Hawaii J Med Public Health       Date:  2012-04

Review 2.  Patient-centered Contraceptive Counseling and Prescribing.

Authors:  Katherine Rivlin; Michelle M Isley
Journal:  Clin Obstet Gynecol       Date:  2018-03       Impact factor: 2.190

3.  Hawai'i Physician Workforce Assessment 2016: Improvement in Physician Numbers but Physician Suicides of Concern.

Authors:  Kelley Withy; Priscilla Mapelli; John Perez; Ariel Finberg; Josh Green
Journal:  Hawaii J Med Public Health       Date:  2017-03

4.  Factors associated with contraceptive choice and inconsistent method use, United States, 2004.

Authors:  Jennifer J Frost; Jacqueline E Darroch
Journal:  Perspect Sex Reprod Health       Date:  2008-06

5.  Rethinking the Pregnancy Planning Paradigm: Unintended Conceptions or Unrepresentative Concepts?

Authors:  Abigail R A Aiken; Sonya Borrero; Lisa S Callegari; Christine Dehlendorf
Journal:  Perspect Sex Reprod Health       Date:  2016-08-11

6.  Implementation science: Scaling a training intervention to include IUDs and implants in contraceptive services in primary care.

Authors:  Cynthia C Harper; Alison B Comfort; Maya Blum; Corinne H Rocca; Charles E McCulloch; Lavanya Rao; Nishant Shah; Helen Oquendo Del Toro; Suzan Goodman
Journal:  Prev Med       Date:  2020-10-21       Impact factor: 4.637

7.  An intervention in contraceptive counseling increased the knowledge about fertility and awareness of preconception health-a randomized controlled trial.

Authors:  Yvonne Skogsdal; Helena Fadl; Yang Cao; Jan Karlsson; Tanja Tydén
Journal:  Ups J Med Sci       Date:  2019-09-09       Impact factor: 2.384

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.